Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Receivables - Other: 2018-2020

Historic Receivables - Other for Wave Life Sciences (WVE) over the last 3 years, with Dec 2020 value amounting to $30.0 million.

  • Wave Life Sciences' Receivables - Other changed negligibly% to $30.0 million in Q1 2021 from the same period last year, while for Mar 2021 it was $30.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $30.0 million for FY2020, which is 40.00% down from last year.
  • Latest data reveals that Wave Life Sciences reported Receivables - Other of $30.0 million as of FY2020, which was down 40.00% from $50.0 million recorded in FY2019.
  • In the past 5 years, Wave Life Sciences' Receivables - Other ranged from a high of $60.0 million in FY2018 and a low of $30.0 million during FY2020.
  • Over the past 3 years, Wave Life Sciences' median Receivables - Other value was $50.0 million (recorded in 2019), while the average stood at $46.7 million.
  • Data for Wave Life Sciences' Receivables - Other shows a maximum YoY tumbled of 40.00% (in 2020) over the last 5 years.
  • Wave Life Sciences' Receivables - Other (Yearly) stood at $60.0 million in 2018, then fell by 16.67% to $50.0 million in 2019, then slumped by 40.00% to $30.0 million in 2020.